Larry M. Simonsmeier Writing Award
The American Society for Pharmacy Law (ASPL) is a nationwide organization with the purposes of: (i) furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues ("Pharmacy Law"); (ii) communicating accurate legal educational information; and (iii) providing education opportunities for pharmacists, attorneys, and others who are interested in Pharmacy Law.
ASPL recognizes outstanding scholarship related to Pharmacy Law with the Simonsmeier Award. The Award recognizes an outstanding paper relating to the interests of ASPL published during the prior two years (2013-2015). The 2016 Award includes an honorarium plus support for travel to the ASPL Developments in Pharmacy Law Seminar XXVII in Austin, Texas, November 9-13, 2016.
The Award is named in honor of the late Larry Simonsmeier (1944-2009), who was a pharmacist and attorney, professor and dean of Washington State University College of Pharmacy, president of ASPL, and editor of the Rx Ipsa Loquitur for more than twenty years.
Papers related to Pharmacy Law, as defined above, published in or accepted for publication in any English-language peer-reviewed journal (including law reviews) during the period from January 2013 through December 2015 are eligible. Interested parties are invited to nominate published papers written by themselves or other authors. Authors may submit manuscripts that are in press.
Submission of Nominations
Nominations should provide the name, address, daytime telephone number, and e-mail address of the nominator, a reprint of the full paper, and a complete journal citation for the paper being nominated. If an author is submitting a manuscript that is in press, the copy of the manuscript should be accompanied by documentation from the journal editor of the status of the paper, and should include contact information for the journal editor. The deadline for submission of nominations for the Larry M. Simonsmeier Award is June 30, 2016.
Nominations should be addressed to:
Education & Scholarship Committee
Questions may be directed to ASPL at:
June 13, 2016
Walgreens terminates relationship with Theranos Inc. following likely CMS sanctions over invalid blood tests
Walgreens announced on June 12 that it will be closing all 40 of its Theranos Wellness Centers in its Arizona stores, and that it is terminating its relationship with Theranos. The announcement follows an earlier decision in January to stop sending blood samples to Theranos' Newark, CA, laboratory, which facility had come under scrutiny by CMS. Walgreens' announcement quoted Brad Fluegel, Senior VP and Chief Health Care Commercial Market Development Officer at Walgreens, as stating, "In light of the voiding of a number of test results, and as the Centers for Medicare and Medicaid Services (CMS) has rejected Theranos' plan of correction and considers sanctions, we have carefully considered our relationship with Theranos and believe it is in our customers' best interests to terminate our partnership. [BusinessWire. Walgreens terminates relationship with Theranos; will be closing operations at all 40 Theranos Wellness Centers in Arizona. 2016 Jun 12; http://bit.ly/1WLIL4J]
2016 DPLXXVII Seminar
November 10-13, 2016